+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Eisai Co - logo

Eisai Limited is a research-based pharmaceutical company that develops, manufactures, and markets healthcare products for patients and their families. It offers products in the areas of Alzheimer's disease, gastrointestinal disorders, epilepsy, cervical dystonia, severe chronic pain, and oncology. The company was founded in 1988 and is based in Hatfield, United Kingdom. It also has operations in the United States, Asia, and Europe.

Company Snapshots: UK Pharmaceuticals - Product Thumbnail Image

Company Snapshots: UK Pharmaceuticals

  • Newsletter
  • May 2025
  • 35 Pages
  • United Kingdom
From
Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2020 - Product Thumbnail Image

Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 90 Pages
  • Global
From
Industry Snapshots: Japan Pharmaceuticals - Product Thumbnail Image

Industry Snapshots: Japan Pharmaceuticals

  • Newsletter
  • May 2025
  • 75 Pages
  • Japan
From
Industry Snapshots: UK Pharmaceuticals - Product Thumbnail Image

Industry Snapshots: UK Pharmaceuticals

  • Newsletter
  • May 2025
  • 50 Pages
  • United Kingdom
From
Company Snapshots: Japan Pharmaceutical - Product Thumbnail Image

Company Snapshots: Japan Pharmaceutical

  • Newsletter
  • May 2025
  • 35 Pages
  • Japan
From
Vaginal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Vaginal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 90 Pages
  • Global
From
Down Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Down Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • February 2022
  • 74 Pages
  • Global
From
Traumatic Brain Injury - Pipeline Review, H2 2020 - Product Thumbnail Image

Traumatic Brain Injury - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 440 Pages
  • Global
From
Neuroimmunology Drug Development - Thematic Research - Product Thumbnail Image

Neuroimmunology Drug Development - Thematic Research

  • Report
  • April 2022
  • 163 Pages
  • Global
From
Impact of Brazil on the Pharmaceutical Industry - Thematic Intelligence - Product Thumbnail Image

Impact of Brazil on the Pharmaceutical Industry - Thematic Intelligence

  • Report
  • December 2022
  • 79 Pages
  • Brazil
From
Glioblastoma Multiforme (GBM): Opportunity Analysis and Forecasts to 2027 - Product Thumbnail Image

Glioblastoma Multiforme (GBM): Opportunity Analysis and Forecasts to 2027

  • Report
  • October 2018
  • 124 Pages
  • Global
From
Parkinson's Disease: Global Drug Forecast and Market Analysis to 2026 - Product Thumbnail Image

Parkinson's Disease: Global Drug Forecast and Market Analysis to 2026

  • Report
  • May 2018
  • 127 Pages
  • Global
From
Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU - Product Thumbnail Image

Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU

  • Report
  • September 2018
  • 162 Pages
  • Global
From
Eisai Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Eisai Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • May 2025
  • 50 Pages
From
Eisai Inc - Strategic SWOT Analysis Review - Product Thumbnail Image

Eisai Inc - Strategic SWOT Analysis Review

  • SWOT Analysis
  • January 2025
  • 30 Pages
From
Eisai Co., Ltd. - Company Profile and SWOT Analysis - Product Thumbnail Image

Eisai Co., Ltd. - Company Profile and SWOT Analysis

  • SWOT Analysis
  • February 2025
  • 44 Pages
From
Eisai Co Ltd (4523) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Eisai Co Ltd (4523) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • August 2024
  • 71 Pages
From
Loading Indicator